Evogene earnings beat by $0.08, revenue topped estimates

Investing.com – Evogene (NASDAQ: ) reported third quarter EPS of $-0.080, $0.08 better than the analyst estimate of $-0.160. Revenue for the quarter came in at $3.77M versus the consensus estimate of $1.2M.

Evogene’s stock price closed at $0.630. It is down -8.560% in the last 3 months and down -13.620% in the last 12 months.

Evogene saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Evogene’s stock price’s past reactions to earnings here.

According to InvestingPro, Evogene’s Financial Health score is “fair performance”.

Check out Evogene’s , and Evogene’s financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar